Item 5. Other Information
Item 5. Other Information
During the quarter ended March 31, 2026 , each of Chief Financial Officer John V. Sakys , Senior Vice President of Continuous Improvement Brian Archbold , and Chief Accounting Officer Lyndsey Crennen entered into a written plan for the sale of Mesa's securities intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5 - 1 (c) (each, a "Rule 10b5 - 1 trading arrangement"). Each Rule 10b5 - 1 trading arrangement was adopted on March 12, 2026 solely to satisfy tax withholding obligations arising from the vesting of equity awards and expired on June 30, 2026 . The Rule 10b5 - 1 trading arrangements provided for the sale of approximately 4,095 , 3,695 and 554 shares of Mesa's common stock for Messrs. Sakys and Archbold and Ms. Crennen, respectively.
Page 24
Table of Contents
Item 6. Exhibits
Exhibit No.
Description of Exhibit
3.1
Amended and Restated Articles of Incorporation of Mesa Laboratories, Inc. (incorporated by reference from Exhibit 3.1 to the Company's Current Report on Form 8-K filed August 25, 2023).
3.2
Amended and Restated Bylaws of Mesa Laboratories, Inc. (incorporated by reference from Exhibit 3.1 to the Company's Current Report on Form 8-K filed May 10, 2019).
10.5.5
Form of Employment Agreement by and among Mesa Laboratories, Inc. and Lyndsey Crennen (incorporated by reference from Exhibit 10.1 to the Company’ s Current Report on Form 8-K filed on June 15, 2026).
31.1+
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2+
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*
Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS+
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH+
Inline XBRL Taxonomy Extension Schema Document.
101.CAL+
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF+
Inline XBRL Taxonomy Extension Definitions Linkbase Document
101.LAB+
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE+
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104+
Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*).
+ Filed herewith
* Furnished herewith
Page 25
Table of Contents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
MESA LABORATORIES, INC.
(Registrant)
DATED: August 10, 2026
BY:
/s/ Siddhartha Kadia, Ph.D .
Siddhartha Kadia
Chief Executive Officer
DATED: August 10, 2026
BY:
/s/ John V. Sakys
John V. Sakys
Chief Financial Officer
Page 26
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.